Tianlong's PCR Diagnostics: Pioneering Technological Advancements in Molecular Diagnostics
Release Date 2023-08-08

As a domestic pioneer in the research and development (R&D) and production of nucleic acid testing instruments and reagents, Tianlong has established itself as a leading provider of comprehensive solutions for genetic testing and molecular diagnostics. With an unwavering commitment to technological advancements, we continue to revolutionize the field of PCR diagnostics, providing cutting-edge solutions that empower healthcare professionals worldwide.

图片4 (1).png

Strategic partnerships and industrial leadership

Our strategic partnerships with global enterprises position us as a leader in professional diagnostic products. By collaborating with renowned organizations, we leverage collective expertise, resources, and market insights to drive innovation. Our emphasis on craftsmanship, perfectionism, and continuous improvement sets the standard for excellence in the industry.

R&D team and independent research

At the heart of Tianlong's success lies our exceptional R&D team comprised of highly qualified professionals from diverse disciplines. These experts contribute our extensive knowledge and experience to fuel breakthrough innovations in PCR diagnostics. Tianlong firmly believes in the power of independent research and development, empowering our team to push boundaries and achieve long-term, high-quality advancements.

Technical innovations and achievements

Tianlong's dedication to technological advancements is exemplified by remarkable achievements in PCR diagnostics. Overcoming challenges such as cross-contamination during nucleic acid extraction, we have developed pioneering techniques that ensure accurate and reliable test results. Furthermore, the integration of MEMS biosensing and multiplexed nucleic acid detection technologies has significantly improved the efficiency and accuracy of nucleic acid detection, setting new benchmarks in the industry.

Contributions to disease prevention and control

We have played a pivotal role in major epidemics, including avian influenza, Ebola, swine fever, and most notably, COVID-19. Our PCR diagnostics have been instrumental in rapidly identifying and tracking infectious diseases, enabling timely interventions and effective containment strategies. Our unwavering commitment to disease prevention and control has earned us prestigious awards and recognition from the global healthcare community.


Tianlong's PCR diagnostics stand at the forefront of technological advancements in molecular diagnostics. Through strategic partnerships, an exceptional R&D team, and a commitment to independent research, Tianlong continues to pioneer groundbreaking solutions that drive the field forward. Our innovative approaches have revolutionized nucleic acid testing, contributing significantly to disease prevention and control during major epidemics. With our unwavering dedication to technological advancements and social responsibilities, we are poised to continue providing first-class molecular diagnostic products while making a meaningful difference in healthcare and beyond.